Protein-based COVID-19 vaccine has obtained emergency use authorisation
PHOTO
China's Livzon Pharmaceutical Group Inc's (Livzon) protein-based COVID-19 vaccine has obtained emergency use authorisation as a booster from the Chinese medical products regulator, the company said in a filing on Friday. (Reporting by Beijing newsroom; editing by Jason Neely)
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
© ZAWYA 2024
